-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
Webinar series: How to use Nu.Q® Vet Cancer Test
- Share
- Tweet
- Share on Facebook
- Share
Interested in learning how to use our Nu.Q® Vet Cancer Test?
If you already realize the value of cancer screening and early detection, then you owe it to yourself to learn how to use our affordable, accessible, and easy-to-use test.
In our series of three webinars, Dr Becca Timmons covers topics from the importance of cancer screening to integrating the Nu.Q® Vet Cancer Test into your veterinary practice.
1. Introducing Canine Cancer Screening: Overcoming Challenges with the Nu.Q® Vet Cancer Test
About the webinar:
The introduction of canine cancer screening represents a paradigm shift in veterinary medicine. This session will explore and address the challenges and reservations veterinarians may face when integrating new tests into their protocol.
From addressing pet owner skepticism to managing operational changes in the clinic, this 0.5 CE credit webinar will delve into potential hurdles, using the Nu.Q® Vet Cancer Test as a guide, will offer solutions to adopt cancer screening into your practice.
Key learning objectives:
- Understand the Landscape: Grasp the current state of canine cancer screening in veterinary care and recognize common reservations among veterinary professionals and pet owners.
- Effective Communication: Learn strategies to effectively communicate the importance and benefits of canine cancer screening to skeptical or unaware pet owners.
- Operational Integration: Learn practical steps and best practices to seamlessly incorporate canine cancer screening into existing clinic workflows and routines.
2. Seamless Integration: Infusing Canine Cancer Screening into Daily Veterinary Practice
About the webinar:
The world of canine cancer screening offers unprecedented opportunities for early detection and intervention. But how do you practically weave this into the fabric of your daily veterinary practice? Dive into the operational nuances of adopting the Nu.Q ® Vet Cancer Test.
From optimizing workflows to enhancing client communication and ensuring staff proficiency, this session provides a comprehensive toolkit for clinics aiming to be at the forefront of canine health. Embrace a transformative approach that not only elevates the care you offer but also positions your practice as a leader in canine cancer screening.
Key learning objectives:
- Operational Adaptation: Understand the key workflow adjustments to incorporate canine cancer screening smoothly and efficiently into daily clinic routines.
- Staff Empowerment: Discover strategies to train and align your clinic staff, ensuring a consistent and effective screening process.
- Client Engagement: Learn impactful methods for educating clients about the significance and benefits of screening, coupled with best practices for post-screening follow-up and care.
3. Interpreting Results, Reading Emotions: The Dual Sensitivities of Canine Cancer Screening
About the webinar:
In the intricate realm of canine cancer screening, understanding the results of the Nu.Q® Vet Cancer Test – whether they indicate low, intermediate, or high risk – is just the beginning. Each risk level can stir a range of emotions in pet owners, from profound relief to pressing anxiety.
This session dives deep into the challenges of not only interpreting these risk levels but also navigating the subsequent emotional responses from pet owners. Equip yourself with tailored strategies to communicate each risk category effectively, address varied concerns, and guide pet owners through their emotions, whether they’re celebrating a low risk or grappling with a high one. By session’s end, you’ll be adept at harnessing the dual power of Nu.Q ® Vet: precise health assessments combined with empathetic, informed communication.
Key learning objectives:
- Recognize the Emotional Spectrum: Understand the range of emotions, from hope to anxiety, that pet owners might experience when considering canine cancer screening for their pets.
- Equip with Empathetic Tools: Acquire strategies and communication techniques to empathetically address pet owner concerns and provide emotional support during the screening process.
- Strengthen Trust and Collaboration: Learn methods to build and maintain a strong bond of trust with pet owners, ensuring collaborative decision-making and a positive screening experience.
4. Detect, treat and monitor: Early Detection Journey with The Nu.Q® Vet Cancer Test
Hosted by: The Webinar Vet – click here to access the webinar.
About the webinar:
In this webinar, we will introduce the Nu.Q® Vet Cancer Test, a pioneering tool in canine cancer screening designed for healthy, asymptomatic dogs.
The session will provide a comprehensive overview of the Nu.Q® Vet Cancer Test, underscoring its significance in advancing early cancer detection in canines. We will explore the scientific principles that form the foundation of the test, focusing on its employment of sophisticated biomarker technology for accurate and timely detection.
Subsequent to the scientific discourse, a series of case studies will be presented. These studies will demonstrate the practical application and efficacy of the Nu.Q® Vet Cancer Test across various clinical settings.
Attendees will gain valuable insights from these real-world examples, understanding how early and precise cancer detection can substantially influence treatment strategies and improve prognostic outcomes.
The webinar will feature Dr. Heather Wilson-Robles, Chief Medical Officer for Volition Veterinary, who is the principal researcher and scientist behind the Nu.Q® Vet Cancer Test. Her expertise will offer a unique perspective on the development and implementation of this innovative screening tool.
RACE # 20-1172396
Key learning objectives:
- Gain Expert Insights from the Test’s Principal Researcher: Benefit from the knowledge and experience of Dr. Heather Wilson-Robles, Chief Medical Officer for Volition Veterinary and the principal researcher behind the Nu.Q® Vet Cancer Test, to understand the developmental journey and future implications of this diagnostic tool in canine health.
- Assess the Impact on Treatment Planning and Prognosis: Learn how early and precise cancer detection via the Nu.Q® Vet Cancer Test can influence treatment decisions.
- Analyze Real-World Applications Through Case Studies: Examine a series of case studies to understand the practical application of the Nu.Q® Vet Cancer Test in various clinical scenarios, providing insights into its effectiveness and utility in a real-world veterinary setting.
- Explore the Scientific Principles Behind the Test: Delve into the biomarker technology that underpins the Nu.Q® Vet Cancer Test, learning about the scientific methodologies and principles that enable its accurate and early detection capabilities.
- Understand the Nu.Q® Vet Cancer Test’s Role in Canine Cancer Detection: Gain a comprehensive understanding of how the Nu.Q® Vet Cancer Test functions as a significant advancement in the early detection of cancer in healthy, asymptomatic dogs, emphasizing its potential impact on veterinary medicine.
To find out more about our Nu.Q® Vet Test, head to our veterinarians page, where you can download our brochure, read the research behind our results and find out where you access the test.
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields